Smith DC - Search Results

1

Adjuvant and neoadjuvant therapy in prostate cancer.

Chay C, Smith DC. Chay C, et al. Among authors: smith dc. Semin Oncol. 2001 Feb;28(1):3-12. doi: 10.1016/s0093-7754(01)90041-7. Semin Oncol. 2001. PMID: 11254863 Review.

2

Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study.

Vaishampayan U, Shevrin D, Stein M, Heilbrun L, Land S, Stark K, Li J, Dickow B, Heath E, Smith D, Fontana J. Vaishampayan U, et al. Urology. 2015 Dec;86(6):1206-11. doi: 10.1016/j.urology.2015.08.008. Epub 2015 Sep 12. Urology. 2015. PMID: 26375845 Free PMC article. Clinical Trial.

3

Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer.

Vaishampayan UN, Fontana J, Heilbrun LK, Smith D, Heath E, Dickow B, Figg WD. Vaishampayan UN, et al. Urol Oncol. 2014 Jan;32(1):31.e25-33. doi: 10.1016/j.urolonc.2012.11.017. Epub 2013 Feb 21. Urol Oncol. 2014. PMID: 23433892 Free PMC article. Clinical Trial.

4

Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience.

Hammad N, Heilbrun LK, Gupta S, Tageja N, Philip PA, Shields AF, Smith D, El-Rayes BF. Hammad N, et al. Am J Clin Oncol. 2011 Apr;34(2):135-9. doi: 10.1097/COC.0b013e3181dbb710. Am J Clin Oncol. 2011. PMID: 20523206 Free PMC article.

5

Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.

Morris R, Alvarez RD, Andrews S, Malone J, Bryant C, Heilbrun LK, Smith D, Schimp V, Munkarah A. Morris R, et al. Gynecol Oncol. 2008 Jun;109(3):346-52. doi: 10.1016/j.ygyno.2008.02.028. Epub 2008 Apr 14. Gynecol Oncol. 2008. PMID: 18410954 Free PMC article. Clinical Trial.

6

Cellular DNA content parameters as prognostic indicators in human astrocytomas.

El-Rayes BF, Norton CS, Sakr W, Maciorowski Z, Smith D, Pietraszkiewicz H, Del Mar Alonso M, Ensley JF. El-Rayes BF, et al. J Neurooncol. 2005 Jan;71(2):85-9. doi: 10.1007/s11060-004-6044-x. J Neurooncol. 2005. PMID: 15690121

7

Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I.

Nakajima K, Heilbrun LK, Hogan V, Smith D, Heath E, Raz A. Nakajima K, et al. Oncotarget. 2016 Dec 13;7(50):82266-82272. doi: 10.18632/oncotarget.12619. Oncotarget. 2016. PMID: 27741512 Free PMC article.

8

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

Hussain M, Vaishampayan U, Du W, Redman B, Smith DC. Hussain M, et al. Among authors: smith dc. J Clin Oncol. 2001 May 1;19(9):2527-33. doi: 10.1200/JCO.2001.19.9.2527. J Clin Oncol. 2001. PMID: 11331332

9

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB. Hussain MH, et al. Among authors: smith dc. J Urol. 2001 Jan;165(1):56-60; discussion 60-1. doi: 10.1097/00005392-200101000-00014. J Urol. 2001. PMID: 11125363 Clinical Trial.

10

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.

Redman BG, Smith DC, Flaherty L, Du W, Hussain M. Redman BG, et al. Among authors: smith dc. J Clin Oncol. 1998 May;16(5):1844-8. doi: 10.1200/JCO.1998.16.5.1844. J Clin Oncol. 1998. PMID: 9586899 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results